ADARx Pharmaceuticals, Inc.
NASDAQ:ADRXBiotechnology
+$0.13 today
- Market cap
- $1.42B
- Beta
- 0.00
Volume 0.65M
Average 1.06M
ADRX EPS (Basic)
Net income attributable to common shareholders divided by the weighted average basic shares outstanding.
EPS (Basic) history
Currency unavailable · from the income statement
No EPS (Basic) data reported for this period type.
EPS (Basic) vs competitors
How ADRX compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Mar 2026 | -€0.44 EUR | -27.1% | — | |
| LTM Mar 2026 | -$1.06 USD | -27.7% | — | |
| LTM Mar 2026 | -$1.11 USD | +35.5% | — | |
| LTM Mar 2026 | -$1.27 USD | +23.5% | — | |
| LTM Mar 2026 | -$1.48 USD | +36.2% | — | |
| LTM Mar 2026 | -$2.83 USD | -436.9% | — | |
| LTM Mar 2026 | -$2.83 USD | -11.9% | — | |
| LTM Mar 2026 | -$4.32 USD | — | — | |
| FY2025 | -$4.48 USD | — | — | |
ADRXADARx Pharmaceuticals, Inc. | — | — | — | — |
| Peer median (excluding ADRX) | — | -11.9% | — | |
Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
ADARx Pharmaceuticals, Inc.
NASDAQ:ADRX
Intrinsic Alpha fair value
Locked
Current Price
$12.82
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.